Real-World Evidence Solutions Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32 - PowerPoint PPT Presentation

About This Presentation
Title:

Real-World Evidence Solutions Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

Description:

According to the latest research report by IMARC Group, The global real-world evidence solutions market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.6% during 2024-2032. More Info:- – PowerPoint PPT presentation

Number of Views:0
Date added: 13 August 2024
Slides: 17
Provided by: MarcelMikaelson
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Real-World Evidence Solutions Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32


1
Global Real-World Evidence Solutions Market
Research and Forecast Report 2024-2032
  • Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group
  • International Market Analysis Research and
    Consulting Group is a leading adviser on
    management strategy and market research
    worldwide. We partner with clients in all regions
    and industry verticals to identify their
    highest-value opportunities, address their most
    critical challenges, and transform their
    businesses.
  • IMARCs information products include major
    market, scientific, economic and technological
    developments for business leaders in
    pharmaceutical, industrial, and high technology
    organizations. Market forecasts and industry
    analysis for biotechnology, advanced materials,
    chemicals, food and beverage, travel and tourism,
    nanotechnology and novel processing methods are
    at the top of the companys expertise.
  • IMARCs tailored approach combines unfathomable
    insight into the dynamics of companies and
    markets with close cooperation at all levels of
    the client organization. This ensures that our
    clients achieve unmatchable competitive
    advantage, build more proficient organizations,
    and secure lasting results.

3
Report Highlight and Description
  • According to the latest report by IMARC Group,
    titled "Real-World Evidence Solutions Market
    Global Industry Trends, Share, Size, Growth,
    Opportunity and Forecast 2024-2032," the global
    real-world evidence solutions market size reached
    US 1.8 Billion in 2023.
  • Factors Affecting the Growth of the Real-World
    Evidence Solutions Industry
  • Growing Data Sources and Integration Techniques
  • With the increasing digitization of healthcare
    records and the proliferation of wearable
    technology, vast amounts of health-related data
    are being generated. This expansion allows for a
    more comprehensive understanding of patient
    outcomes in real-world settings. Moreover,
    advancements in data integration technologies
    facilitate the merging of diverse data types,
    including electronic health records (EHRs),
    insurance claims, and patient-reported outcomes.
  • This integration enhances the quality and
    granularity of real-world evidence (RWE), making
    it more valuable for healthcare decision-making.
    This evolution is pivotal for pharmaceutical
    companies, regulatory agencies, and healthcare
    providers, as it enables more informed decisions
    regarding drug development, market access
    strategies, and treatment approaches.

4
Report Highlight and Description
  • Regulatory Environment and Policy Support
  • Regulatory agencies are recognizing the
    importance of RWE in supplementing randomized
    controlled trial (RCT) data. This recognition is
    translating into guidelines and frameworks that
    encourage the use of RWE in the approval of new
    drugs and the expansion of existing drug
    indications.
  • Additionally, policies advocating for the
    adoption of EHRs and the interoperability of
    health data systems are encouraging the use of
    RWE by improving the accessibility and quality of
    real-world data. This regulatory support ensures
    that RWE continues to play a crucial role in the
    evidence hierarchy, influencing drug development,
    market access, and post-market surveillance
    strategies.
  • Technological Advancements in Data Analytics
  • The development and application of sophisticated
    analytical tools and algorithms, including
    artificial intelligence (AI) and machine learning
    (ML), are enhancing the ability to process and
    analyze large datasets. These technologies
    facilitate the extraction of meaningful insights
    from complex and unstructured real-world data,
    enabling more accurate and efficient analyses
    than previously possible.

5
Report Highlight and Description
  • The ability to quickly derive actionable insights
    from vast amounts of data is invaluable for
    pharmaceutical companies, healthcare providers,
    and policymakers. This capability supports a wide
    array of applications, ranging from drug
    development and patient monitoring to health
    economics and outcomes research.
  • Request for a PDF sample of this report
    https//www.imarcgroup.com/real-world-evidence-sol
    utions-market/requestsample

6
Report Description
  • Global Real-World Evidence Solutions Market
    Trends
  • The growing integration of RWE with digital
    health technologies, such as telehealth services,
    mobile health (mHealth) apps, and wearable
    devices, for collecting and analyzing health data
    in real time is offering a more dynamic and
    continuous insight into patient health and
    behavior outside of traditional healthcare
    settings. Digital health technologies enable the
    capture of a vast array of data points, ranging
    from physiological metrics to patient-reported
    outcomes, which can be analyzed using RWE
    methodologies to generate more personalized and
    timely insights into treatment effectiveness and
    patient adherence.
  • This convergence of digital health and RWE opens
    novel avenues for healthcare innovation, allowing
    for the development of more holistic and
    patient-centered care models that can adapt to
    the changing needs and conditions of patients in
    real-time.
  • View Report TOC, Figures and Tables
    https//www.imarcgroup.com/real-world-evidence-sol
    utions-market

7
Report Segmentation
  • Breakup by Component
  • Clinical Settings Data
  • Claims Data
  • Patient-Powered Data
  • Pharmacy Data
  • Others
  • Breakup by Therapeutic Area
  • Oncology
  • Immunology
  • Neurology
  • Cardiovascular Disease
  • Others

8
Report Segmentation
  • Breakup by End User
  • Pharmaceutical and Medical Device Companies
  • Healthcare Payers
  • Healthcare Providers
  • Others
  • Breakup by Region
  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

9
Competitive Landscape with Key Players
  • Aetion Inc.
  • Clinigen Limited
  • Flatiron Health Inc. (Roche Holding AG)
  • ICON plc
  • International Business Machines Corporation
  • IQVIA
  • Optum Inc. (UnitedHealth Group Incorporated)
  • Oracle Corporation
  • Parexel International Corporation
  • PPD Inc. (Thermo Fisher Scientific Inc.)
  • Sas Institute Inc.
  • Syneos Health

10
Key Questions Answered in the Report
11
Table of Contents
  • 1    Preface2    Scope and Methodology    2.1  
     Objectives of the Study    2.2  
     Stakeholders    2.3    Data Sources       
    2.3.1    Primary Sources        2.3.2  
     Secondary Sources    2.4    Market Estimation 
          2.4.1    Bottom-Up Approach        2.4.2  
     Top-Down Approach    2.5    Forecasting
    Methodology3    Executive Summary4  
     Introduction    4.1    Overview    4.2    Key
    Industry Trends5    Global Real-World Evidence
    Solutions Market    5.1    Market Overview   
    5.2    Market Performance    5.3    Impact of
    COVID-19  5.4    Market Forecast
  • 6     Market Breakup by Component
  • 6.1 Clinical Settings Data
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
  • 6.2 Claims Data
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
  • 6.3 Patient-Powered Data
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast       

12
Table of Contents
  • 6.4 Pharmacy Data
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
  • 6.5 Others
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
  • 7 Market Breakup by Therapeutic Area
  • 7.1 Oncology
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
  • 7.2 Immunology
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
  • 7.3 Neurology
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
  • 7.4 Cardiovascular Disease
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

13
Partial List of Clients
14
Partial List of Clients
15
Disclaimer
  • 2024 IMARC All Rights Reserved
  • This Publication and all its contents unless
    otherwise mentioned are copyrighted in the name
    of International Market Analysis Research and
    Consulting (IMARC). No part of this publication
    may be reproduced, repackaged, redistributed or
    resold in whole or in any part. The publication
    may also not be used in any form or by and means
    graphic electronic or mechanical, including
    photocopying, recording, taping or by information
    storage or retrieval, or by any other form,
    without the express consent of International
    Market Analysis Research and Consulting (IMARC).
  • Disclaimer All contents and data of this
    publication, including forecasts, data analysis
    and opinion have been based on information and
    sources believed to be accurate and reliable at
    the time of publishing. International Market
    Analysis Research and Consulting makes no
    representation of warranty of any kind as to the
    accuracy or completeness of any Information
    provided. IMARC accepts no liability whatsoever
    for any loss or damage resulting from opinion,
    errors or inaccuracies if any found this
    publication.
  • IMARC, IMARC Group and Global Therapy Insight
    Series are registered trademarks of International
    Market Analysis Research and Consulting. All
    other trademarks used in this publication are
    registered trademarks of their respective
    companies.

16
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us
Write a Comment
User Comments (0)
About PowerShow.com